Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-27

Clinical Trial Update: Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders [NA]

View source ↗

Summary

A completed clinical trial investigating intranasal oxytocin for autism spectrum disorders; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • intranasal oxytocin (oxytocin)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Autism Spectrum Disorders | NA | Status: COMPLETED | Results posted: 2020-02-27